Telehealth and virtual care

Win and keep virtual patients, with ad-platform and privacy rules built in

We design intake, acquisition and retention workflows that measure results in your own systems, with clinicians and compliance owners in the loop.

Short answer

How can AI help telehealth companies?

AI helps virtual care providers with intake summaries for clinician review, scheduling and support chat, ad and landing-page drafting under compliance review, and billing support. The harder problems are acquisition under platform health policies, privacy of tracking data, retention and reimbursement. AI should not diagnose, prescribe or triage symptoms without qualified oversight, and results depend on your funnel data.

Who this covers

Organizations in this segment

  • Direct-to-consumer telehealth companies
  • Virtual urgent care and virtual primary care providers
  • Hybrid practices adding video and asynchronous visits
  • Online prescribing and weight management services
  • UK online clinics and digital GP services
Challenges

The business problems that hold this segment back

01

Ad platforms gate the main acquisition channels

Google requires certification for telemedicine and prescription services, and some routes first need third-party accreditation such as LegitScript, NABP or G2. Meta requires proof of licensing and its permission to promote prescription drugs. A disapproved ad account can stop the funnel until it is reinstated.

02

Tracking can become an enforcement event

The FTC has acted against telehealth firms over health data sent to advertisers and over cancellation practices. Pixels, hashed customer lists and server-side events all count, and non-HIPAA health apps face consumer health data laws and the FTC Health Breach Notification Rule.

03

Conversion lives inside an asynchronous intake

People start a questionnaire, upload ID, pay and wait for a clinician. Every extra step, unclear price or slow review loses someone, and you cannot see why if you cannot send condition data to analytics tools.

04

Retention is a regulated experience

Subscriptions, renewals and cancellations draw complaints and regulators alike. Retention work should make leaving easy to find, because the FTC has alleged deceptive cancellation practices in cases against telehealth companies.

05

Reimbursement is not settled

CMS says Medicare telehealth location flexibilities run through 31 December 2027, with a billing-method change for rural health clinics and federally qualified health centers from October 2026. Payer enrollment, credentialing and claims need to survive rule changes.

Where AI fits

Suitable AI, and how mature each application is

Established means widely deployed and well documented. Emerging means real deployments exist but results vary with your data and workflow. Early means pilots or research, not a safe default.

Established

Intake summaries and visit notes for clinicians

AI condenses the questionnaire and visit transcript into a draft for the clinician to edit and sign. Test clinician-reviewed documentation on your own visit types, because the published evidence is not specific to telehealth.

Established

Scheduling, status and support chat

Bounded chat handles booking, prescription-refill status questions and shipping or billing queries, verifies identity before disclosing anything and passes red-flag words to a clinician. AI agents must also disclose that they are AI where state law requires.

Emerging

Ad and landing-page drafting with compliance review

AI drafts variants and summarizes performance. A person with compliance duty approves every claim, and creative must describe the service instead of telling a viewer they have a condition.

Emerging

Retention signals from first-party data

Models can flag members who stop engaging so support can reach out. Evidence of lift is thin, and outreach must respect consent.

Emerging

Eligibility, enrollment and claim support

Document extraction for payer enrollment packets, eligibility checks and claim status follow task-level patterns that are already proven in revenue cycle work. Telehealth-specific results are less documented.

Early

Symptom checking and treatment suggestions

AI triage should be described as evaluated or rolling out at a stated scale, not as independently proven to replace a clinician. FDA's January 2026 guidance says patient-facing software can remain a regulated device.

What stays human

Responsibilities that stay with your people

Medical director

Sets clinical protocols, red-flag rules and the list of things the system may never say, and is the point of escalation for safety events.

Prescribing clinicians

Make every diagnosis and prescribing decision. Intake summaries inform them and never decide for them.

Compliance and privacy officer

Approves ad claims, audits trackers and forms, owns consent records and keeps platform certifications current. AI governance gives that role a register and an evidence trail.

Patient support lead

Handles cancellations, billing disputes and upset patients, and checks that automated replies never block a cancellation.

Billing and enrollment manager

Owns payer enrollment, claim submission and appeals, and watches coverage changes.

Improvements

Operational changes you can expect to work on

01

More intakes completed

Track started versus completed intakes, abandonment by step and the time from inquiry to first clinician contact.

02

Acquisition that survives audit

Measure cost per qualified consult in your own CRM, ad disapprovals and tracker findings per audit.

03

Clearer retention

Track cancellation reasons, rebooking, complaint rate and the number of steps to cancel.

04

Cleaner payer billing

Track first-pass claim acceptance, days in accounts receivable and enrollment status by payer.

Commercial value

Cost per patient, conversion and retention decide the model

Virtual care margins are set by what it costs to acquire a patient, how many finish intake and how long they stay. We link AI work to those numbers through digital marketing that fits platform health policies and measurement held in your own systems.

  • Attract: policy-compliant paid campaigns, content and, in the UK, organic search through search work.
  • Convert: recover abandoned intakes with first-party, consented messages and answer questions quickly.
  • Retain: onboarding sequences, clear renewal terms and follow-up that clinicians approve.
  • Grow: partnerships with employers, clinics and pharmacies, with referral source tracking.
  • Protect revenue: payer enrollment tracking and cleaner claims.
Rules and limits

US and UK rules that apply, and what is not ready yet

General information for planning, not legal advice. Statuses and dates are as published at the time of writing.

United States

  • Google certification is required for telemedicine and prescription-drug services, and LegitScript is a route for some models, not a universal rule. Meta requires licensing proof and has a permission process for prescription drugs. Customer Match and advertiser-curated audiences cannot be used for sensitive health interests, and Meta prohibits sending sensitive health information through its Business Tools.
  • FTC actions include a proposed Cerebral order (April 2024) over health-data sharing in advertising and cancellation practices, and a NextMed final order (3 December 2025) over deceptive pricing and fake reviews. On 29 July 2026 the FTC and states sued a telehealth company over health-data sharing and cancellation practices, which are allegations, not findings. The amended Health Breach Notification Rule (29 July 2024) remains in force after the FTC withdrew a 2021 policy statement on 9 September 2026.
  • Washington's My Health My Data Act and Nevada SB 370 (both 31 March 2024 for main duties), Connecticut and Maryland regulate consumer health data outside HIPAA. For PHI, a court narrowed OCR's tracking bulletin on 20 June 2024 for unauthenticated public pages, while appointment and symptom-entry data can still be PHI.
  • CMS says Medicare telehealth location flexibilities run through 31 December 2027. FDA's clinical decision support guidance (6 and 29 January 2026) asks you to test each software function, and Texas HB 149 (1 January 2026) requires disclosure of AI use in a healthcare service.

United Kingdom

  • CAP rule 12.12 bars advertising prescription-only medicines to the public. MHRA's September 2026 advertising investigations note says treatment-service ads must not promote prescription-only weight-loss medicines, including indirect GLP-1 references. Platform permission does not override this.
  • Google allows UK online pharmacy and telemedicine ads with limitations. Advertising pixels need prior consent under PECR, health data needs an Article 9 condition under UK GDPR, and ICO advises explicit consent when health information selects marketing recipients.
  • CQC does not approve AI products but expects registered providers to show human oversight and patient information. NHS England is targeting more than 200,000 patients for NHS App AI triage over 12 months, and it is not yet universal.
Not mature or not suitable yet
  • Patient-facing symptom checkers and treatment recommenders without clinician review. Regulation, evidence and liability are unsettled.
  • Sending condition-level events, hashed patient lists or conversion data to ad platforms to improve targeting.
  • Mental-health chatbots offered as therapy. Several US states restrict this, as covered under mental health organizations.
Where to start

Where we would begin

  1. 01

    Audit tracking and platform status

    List every pixel, event, form field and customer list, check platform certifications and fix what exposes health data before spending more.

  2. 02

    Rebuild the intake funnel

    Map each step from inquiry to first visit, add consent capture and measure abandonment in your own CRM so revenue operations can act on real numbers.

  3. 03

    Add AI where review is easy

    Start with intake summaries and scheduling chat. Defer triage and recommendation features until evidence and regulation are clear.

Questions

Frequently asked questions

Do telehealth ads need LegitScript?

Not universally. Google's certification route depends on your business model and location, and some applications first need accreditation from LegitScript, NABP or G2. In the US, addiction-treatment ads need LegitScript certification. Check the current policy for your service before budgeting.

Can we retarget people who started an intake?

Be very careful. Google blocks Customer Match and advertiser-curated audiences for sensitive health interests, Meta prohibits sending sensitive health information through its tools, and FTC actions have targeted such sharing. Recover abandoned intakes with first-party, consented messages instead.

Which privacy laws apply to a telehealth business?

Usually more than one. HIPAA covers covered entities and business associates, non-HIPAA health apps may face the FTC Health Breach Notification Rule and state consumer health data laws, and UK operators face UK GDPR and PECR. Map your data flows first, then check with qualified counsel.

Can an AI chatbot triage symptoms for patients?

Not as an unsupervised replacement for a clinician. NHS App triage is being rolled out after a trial and is still being evaluated, and FDA says patient-facing functions can remain devices. Use chat for scheduling and routing, and send red-flag phrases to a person.

Will Medicare telehealth flexibilities last?

CMS says the relevant location flexibilities run through 31 December 2027. Do not build a model that assumes permanence, and track the billing-method change for rural health clinics and federally qualified health centers from October 2026.

Start with the funnel and the tracking

Bring your intake flow, your ad accounts and your current reporting. We will show where AI can help and where the privacy and platform rules set the limits.

Book a discovery call
error: Content is protected !!